Quality Seal Emagister EMAGISTER CUM LAUDE

Making Biologic Medicines for Patients: The Principles of Biopharmaceutical Manufacturing - Massachusetts Institute of Technology



Important information

  • Course
  • Online
  • When:

Learn how protein therapeutics are manufactured and explore the fundamental principles of biopharmaceutical manufacturing.With this course you earn while you learn, you gain recognized qualifications, job specific skills and knowledge and this helps you stand out in the job market.

Important information

Requirements: Basic understanding of organic chemistry, calculus, and molecular biology.


Where and when

Starts Location

What you'll learn on the course

Biopharmaceutical Manufacturing

Course programme

Humans have leveraged the power of cells for millennia to produce staples such as bread, cheese, beer and wine. Yet only recently have we begun to utilize cells as factories for the production of protein therapeutics. These biologic drugs are able to treat otherwise untreatable diseases. In this course, you will learn how these life saving medicines are made. We will connect the engineering fundamentals to real-world application by showing real pieces of biomanufacturing equipment in action and listening to experts describe real-world engineering challenges.

Additional information

J. Christopher Love J. Christopher Love is an Associate Professor of Chemical Engineering at the Koch Institute for Integrative Cancer Research at MIT. He is also an Associate Member of the Broad Institute, and an Associate Member at the Ragon Institute of MGH, MIT, and Harvard. Prof. Love earned a B.S. in chemistry from the University of Virginia and a Ph.D. in physical chemistry at Harvard University.  Anthony J. Sinskey Anthony J. Sinskey is a Professor of Microbiology and Engineering Systems at the Massachusetts Institute of Technology. He also holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership Program and as Faculty Director of the MIT Center for Biomedical Innovation (CBI).